Denmark's Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition [Fortune]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Fortune
More than 25,000 patients are now starting on the treatment each week in the US, Chief Executive Officer Lars Fruergaard Jorgensen said Thursday. That's up from about 5,000 in December. Ramping up production is a key element of Novo's strategy as it battles Eli Lilly & Co. for supremacy in the weight-loss market. The pharma company is doubling its investment in manufacturing capacity this year to about $6.4 billion — a figure that doesn't include the planned $11 billion acquisition of three factories originally owned by contract manufacturer Catalent Inc. Demand for the obesity blockbuster and its sister medicine for diabetes Ozempic prompted the Danish company to increase its forecast on Thursday, saying sales could surge as much as 27% and operating profit by as much as 30% this year. The shares fell 2.3% in early trading in Copenhagen. They have surged about 25% this year and almost doubled since the start of 2023. Wegovy Sales Price pressure on Wegovy in the US held bac
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Stanley Druckenmiller makes surprising small-cap and AI stock bet [Yahoo! Finance]Yahoo! Finance
- Investors put $400M into biotech licensing obesity drugs from China [Yahoo! Finance]Yahoo! Finance
- Viking falls after Roche's obesity drug data [Seeking Alpha]Seeking Alpha
- 3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance [Yahoo! Finance]Yahoo! Finance
- Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 5/9/24 - Form 8-K
- 5/3/24 - Form SD
- 4/30/24 - Form 10-Q
- LLY's page on the SEC website